Agios Pharmaceuticals
AGIO
#4817
Rank
HK$15.15 B
Marketcap
HK$258.69
Share price
-2.21%
Change (1 day)
35.88%
Change (1 year)

Agios Pharmaceuticals (AGIO) - Cash on Hand

Cash on Hand as of December 2025 : HK$6.69 Billion

According to Agios Pharmaceuticals 's latest financial reports the company has HK$6.69 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Agios Pharmaceuticals - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$6.64 B-4.18%
2024-12-31HK$6.93 B14.35%
2023-12-31HK$6.06 B-0.83%
2022-12-31HK$6.11 B-23.07%
2021-12-31HK$7.95 B79.08%
2020-12-31HK$4.44 B0.96%
2019-12-31HK$4.39 B-4.02%
2018-12-31HK$4.58 B38.38%
2017-12-31HK$3.31 B-21.09%
2016-12-31HK$4.19 B70.85%
2015-12-31HK$2.45 B-7.4%
2014-12-31HK$2.65 B105.17%
2013-12-31HK$1.29 B30.37%
2012-12-31HK$0.99 B-28.72%
2011-12-31HK$1.39 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$106.50 B 1,491.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$56.93 B 750.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$33.32 B 397.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
HK$4.29 B-35.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$8.29 B 23.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.22 B 82.65%๐Ÿ‡บ๐Ÿ‡ธ USA